Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 5/20 | 0.74 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.74 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.74 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.74 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.74 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.74 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.74 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.74 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.74 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.74 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.70 |
| ▸ | MGAM | O43451 | 2/20 | 0.55 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | SI | P14410 | 2/20 | 0.55 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12430571 | 0.92 | HDAC3 (0.73) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL7413562 | 0.91 | HDAC3 (0.71) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL69679 | 0.91 | HDAC3 (0.69) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL69680 | 0.89 | HDAC3 (0.63) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL4868536 | 0.88 | HDAC3 (0.71) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL2298574 | 0.88 | HDAC3 (0.71) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL6539230 | 0.88 | HDAC3 (0.80) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL4953766 | 0.88 | HDAC3 (0.80) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL7317724 | 0.86 | HDAC3 (1.00) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL8827885 | 0.86 | HDAC3 (0.68) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7582737-B2 | Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides | ACADEMIA SINICA (TW) | 2009-09-01 | — | — | US | claimed |
| CN-101289475-A | Process for selectively synthesizing sucrose-6-ester | CHANGZHOU NIUTANG CHEMICAL PLA (CN) | 2008-10-22 | — | — | CN | claimed |
| US-20250007001-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2025-01-02 | — | — | US | disclosed |
| US-20240250306-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2024-07-25 | — | — | US | disclosed |
| WO-2023170799-A1 | LITHIUM SECONDARY BATTERY | ＴｅｒａＷａｔｔ Ｔｅｃｈｎｏｌｏｇｙ株式会社 | 2023-09-14 | — | — | WO | disclosed |
| US-20230261203-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230261203-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230261203-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2023-08-17 | — | — | US | disclosed |
| WO-2023053295-A1 | LITHIUM SECONDARY BATTERY | ＴｅｒａＷａｔｔ Ｔｅｃｈｎｏｌｏｇｙ株式会社 | 2023-04-06 | — | — | WO | disclosed |
| WO-2022085046-A1 | LITHIUM SECONDARY BATTERY | ＴｅｒａＷａｔｔ Ｔｅｃｈｎｏｌｏｇｙ株式会社 | 2022-04-28 | — | — | WO | disclosed |
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
| EP-1322673-A1 | POLYSACCHARIDES WITH ANTITHROMBOTIC ACTIVITY COMPRISING AT LEAST A COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE | Sanofi-Aventis (FR) | 2003-07-02 | — | — | EP | disclosed |
| US-6534481-B1 | Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin | SANOFI-SYNTHELABO (FR) | 2003-03-18 | — | — | US | disclosed |
| EP-0912613-B1 | SYNTHETIC POLYSACCHARIDES, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SANOFI SYNTHELABO (FR) | 2002-09-25 | — | — | EP | disclosed |
| WO-2002024754-A1 | POLYSACCHARIDES WITH ANTITHROMBOTIC ACTIVITY COMPRISING AT LEAST A COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE | SANOFI-SYNTHELABO (FR) | 2002-03-28 | — | — | WO | disclosed |
| EP-1049721-B1 | SYNTHETIC POLYSACCHARIDES, THEIR METHOD OF PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SANOFI SYNTHELABO (FR) | 2001-11-21 | — | — | EP | disclosed |
| CN-1228785-A | Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same | SANOFI SA (FR) | 1999-09-15 | — | — | CN | disclosed |
| US-4388233-A | PROTEOLYTIC ENZYMES, FLUORIMETRIC ANALYSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1983-06-14 | — | — | US | disclosed |
| US-4242507-A | Sulfonic acid esters | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-12-30 | — | — | US | disclosed |
| US-4075220-A | FOR POLYMERS | EASTMAN KODAK COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | HDAC3 4081/4885HDAC4 4114/4885HDAC1 3911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.